{"id":781867,"date":"2023-09-05T16:30:36","date_gmt":"2023-09-05T20:30:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/"},"modified":"2023-09-05T16:30:36","modified_gmt":"2023-09-05T20:30:36","slug":"miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/","title":{"rendered":"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">EDEN PRAIRIE, Minn., Sept.  05, 2023  (GLOBE NEWSWIRE) &#8212; Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients&#8217; lives, announced its participation in the upcoming Alliance for Regenerative Medicine (ARM) Tissue Engineering and Therapeutics Workshop held on September 6, 2023.<\/p>\n<p>Miromatrix Medical is scheduled to present at the ARM Tissue and Engineering and Therapeutics Workshop for three sessions:<\/p>\n<ul type=\"disc\">\n<li>9:00am ET: Bioengineering Transplantable Organs to Address the Transplant Need<\/li>\n<li>1:00pm ET: CMC Perspectives \u2013 Delivery, Stability, Potency<\/li>\n<li>3:30pm ET: Regulatory Perspectives<\/li>\n<\/ul>\n<p>The Alliance for Regenerative Medicine Workshop will highlight scientific advances, CMC and regulatory insights, and funding perspectives.<\/p>\n<p>\n        <strong>About Miromatrix<\/strong><br \/>\n        <br \/>Miromatrix Medical Inc.\u00a0is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients&#8217; lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company&#8217;s initial development focus is on human livers and kidneys. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rRyjwzHTmTUgZKeDyIhSDBd9QDTbQ9tRjger1ZyiQYGNJwk0iWPCeTLWCszUHfQR_CtrjOruXsGoKWHk6yuquWpGvYXmwRa3frHp4MyW1eruZ5QYI3cH3C_BrCncZk-uFvPtcKxv3kkdZ7BRWWOSE-jazVmi1TIYCk8ZHlbhiOLDtQZ4IOt6m1gd7pNtJ1uejpUQKCPHjb1Me6kwiXQfhoeUvszL0L7t5H7J6G5fA8U=\" rel=\"nofollow noopener\" target=\"_blank\">miromatrix.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Greg Chodaczek<br \/>347-620-7010 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VBb3O8Gg4aaLEpl9P6ITHmnbHzqsQVQ8wxjt46HlXhWOu-aI3WWoC5vU67QamfnOAkl1vQtSSTad9ZGOuAK--pMSqdq58wuAlu8WTtiWoI4=\" rel=\"nofollow noopener\" target=\"_blank\">ir@miromatrix.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Christina Campbell<br \/>612-924-3793<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u7ctY4La25re9tQ1bgqFASadnGK8Vy5s0eHlS3SckQeiFo5INOdsMfNULUoAv8T5hkF6RSKYCAGk-R9_3AtqiC7rSXJtJY95T97P3WduLW9-btEPmzOtyowA-n_XYaUxiwLfSxuCu23JFDk2RsdrsRl2Vq3Wtrq-mWq4KhC0MzfrQBxcHzG8_oPHd9A7ZS3GecBtOfd2ri8CquFh6nhLM-ORmeFmISkUwTvXZwikdIVBxCJxTT972dqs9gF_oOgPponxRVFWg65LrcIYdhIbWg8Y_w7F2I1lXfjS6EKBtlc=\" rel=\"nofollow noopener\" target=\"_blank\">Christina@media-minefield.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YjVlNjNiZjQtZTQ0My00ODMyLTk4ZDYtM2U5NDFjMTFhYzFiLTEyMjIwNzM=\/tiny\/Miromatrix-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EDEN PRAIRIE, Minn., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients&#8217; lives, announced its participation in the upcoming Alliance for Regenerative Medicine (ARM) Tissue Engineering and Therapeutics Workshop held on September 6, 2023. Miromatrix Medical is scheduled to present at the ARM Tissue and Engineering and Therapeutics Workshop for three sessions: 9:00am ET: Bioengineering Transplantable Organs to Address the Transplant Need 1:00pm ET: CMC Perspectives \u2013 Delivery, Stability, Potency 3:30pm ET: Regulatory Perspectives The Alliance for Regenerative Medicine Workshop will highlight scientific advances, CMC and regulatory insights, and funding perspectives. About Miromatrix Miromatrix Medical Inc.\u00a0is a life sciences &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781867","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"EDEN PRAIRIE, Minn., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients&#8217; lives, announced its participation in the upcoming Alliance for Regenerative Medicine (ARM) Tissue Engineering and Therapeutics Workshop held on September 6, 2023. Miromatrix Medical is scheduled to present at the ARM Tissue and Engineering and Therapeutics Workshop for three sessions: 9:00am ET: Bioengineering Transplantable Organs to Address the Transplant Need 1:00pm ET: CMC Perspectives \u2013 Delivery, Stability, Potency 3:30pm ET: Regulatory Perspectives The Alliance for Regenerative Medicine Workshop will highlight scientific advances, CMC and regulatory insights, and funding perspectives. About Miromatrix Miromatrix Medical Inc.\u00a0is a life sciences &hellip; Continue reading &quot;Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-05T20:30:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop\",\"datePublished\":\"2023-09-05T20:30:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/\"},\"wordCount\":206,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/\",\"name\":\"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=\",\"datePublished\":\"2023-09-05T20:30:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/","og_locale":"en_US","og_type":"article","og_title":"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop - Market Newsdesk","og_description":"EDEN PRAIRIE, Minn., Sept. 05, 2023 (GLOBE NEWSWIRE) &#8212; Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients&#8217; lives, announced its participation in the upcoming Alliance for Regenerative Medicine (ARM) Tissue Engineering and Therapeutics Workshop held on September 6, 2023. Miromatrix Medical is scheduled to present at the ARM Tissue and Engineering and Therapeutics Workshop for three sessions: 9:00am ET: Bioengineering Transplantable Organs to Address the Transplant Need 1:00pm ET: CMC Perspectives \u2013 Delivery, Stability, Potency 3:30pm ET: Regulatory Perspectives The Alliance for Regenerative Medicine Workshop will highlight scientific advances, CMC and regulatory insights, and funding perspectives. About Miromatrix Miromatrix Medical Inc.\u00a0is a life sciences &hellip; Continue reading \"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-05T20:30:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop","datePublished":"2023-09-05T20:30:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/"},"wordCount":206,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/","name":"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=","datePublished":"2023-09-05T20:30:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNjk2OSM1Nzk5NjM3IzIyMTA1MjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-announces-participation-in-the-arm-tissue-engineering-and-therapeutics-workshop\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781867"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781867\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}